A35

N/A

Report date: 2023/11/13 09:36:15
NME

Base Information

Drug NameA35
Drug Alias NameA35A-35
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang UniversityZhejiang Chinese Medical University
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Chinese Medical UniversityZhejiang University
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A